Funding news · Nov 13, 2026

Votum Labs Raises €1.2M Seed for Science-Backed Health and Veterinary Brands

Votum Labs Closes €1.2 Million Seed Round

Votum Labs, a Spanish biotechnology laboratory, has raised a €1.2 million Seed round. No lead investor was named in the round, and no individual investors were disclosed.

Company Background

Votum Labs was founded in 2021 and is headquartered in Lorqui, Murcia, Spain. The company develops science-backed health and wellness products for both human and veterinary use.

Its own-brand portfolio spans dermopharmaceuticals and consumer health, and includes:

  • Cronidol
  • Sportidol
  • Vezelay Lab
  • SOS by Happy Pets
  • Cronipets

These brands are sold through pharmacy, veterinary, and specialized distribution channels in Spain and internationally.

Research and IP Focus

Beyond its commercial brands, Votum Labs conducts in-house research into proprietary formulations and intellectual-property projects focused on musculoskeletal health. This research layer underpins the company's positioning as a biotechnology laboratory rather than a pure consumer-products distributor.

What the Funding Signals

The Seed round provides capital to a company that already operates a multi-brand portfolio across two distinct markets: human dermopharmaceuticals and consumer health on one side, and veterinary products on the other. The dual human-and-animal model, combined with pharmacy and specialized distribution reach in Spain and abroad, gives Votum Labs a diversified commercial base at the seed stage.

Key Facts

  • Company: Votum Labs
  • Founded: 2021
  • Headquarters: Lorqui, Murcia, Spain
  • Sector: Biotechnology — human and veterinary health and wellness
  • Brands: Cronidol, Sportidol, Vezelay Lab, SOS by Happy Pets, Cronipets
  • Channels: Pharmacy, veterinary, and specialized distribution in Spain and internationally
  • Research focus: Proprietary formulations and IP projects in musculoskeletal health
  • Round: Seed
  • Amount: €1.2 million
  • Lead investor: Not disclosed

Acquisition Perspective

Votum Labs offers a portfolio of established own-brand products across human and veterinary categories, supported by in-house formulation research and IP work in musculoskeletal health. For acquirers in consumer health, dermopharmaceuticals, or veterinary products, the company presents a multi-brand platform with existing distribution relationships in Spain and international markets. The new seed capital is positioned to support the company as it builds on that commercial and research base.

© 2026 VeilStrat. All rights reserved.All systems operational